Associated Papers
Galloway-mowat syndrome 3 (GAMOS3): a novel disease-causing variant in OSGEP gene and expansion of the clinical spectrum.
Yari A et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025
Galloway-Mowat Syndrome Type 3 Caused by OSGEP Gene Variants: A Case Report and Literature Review.
Xu S et al.
Frontiers in Pediatrics, 2022
35783322 (PubMed )
Supplement: Data_Sheet_1.PDF
Increase in diagnostic yield achieved for 174 whole-exome sequencing cases reanalyzed 1-2 years after initial analysis.
Liu Y et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2021
Novel variants in OSGEP leading to Galloway-Mowat syndrome by altering its subcellular localization.
Teng H et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2021
Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes.
Li R et al.
Nature Communications, 2021
34145257 (PubMed )
Supplement: 41467_2021_24043_MOESM5_ESM.xlsx › Sheet1
Select a paper to view details